Tenet Healthcare Corp. 10-Q Summary: Q3 2025
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2025. Tenet Healthcare Corporation operates a nationwide network of acute care and specialty hospitals (Hospital Operations) and ambulatory surgery centers (Ambulatory Care). As of the reporting date, the company operated 50 hospitals and held interests in 530 ambulatory surgery centers. The company is a large accelerated filer incorporated in Nevada.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Net Operating Revenues | $5,289 million | $5,126 million | $15,783 million | $15,602 million |
| Operating Income | $889 million | $1,089 million | $2,655 million | $5,135 million |
| Net Income (Total) | $579 million | $681 million | $1,723 million | $3,492 million |
| Net Income to Common Shareholders | $342 million | $472 million | $1,036 million | $2,882 million |
| Diluted EPS (Common) | $3.86 | $4.89 | $11.28 | $29.27 |
| Operating Cash Flow (YTD) | $2,809 million (2025) vs $2,378 million (2024) | |||
| Cash and Equivalents | $2,975 million (as of Sept 30, 2025) | |||
| Total Debt (Long-term + Current) | $13,272 million (as of Sept 30, 2025) |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net operating revenues increased 3.2% in Q3 2025 and 1.2% YTD 2025 compared to the prior year. The Ambulatory Care segment drove growth with an 11.9% increase in Q3 revenues, while Hospital Operations grew 0.7%.
- Profitability Decline: Operating income decreased significantly year-over-year (18.4% in Q3; 48.3% YTD). This decline is primarily attributable to the absence of $2.9 billion in net gains on sales of facilities recognized in the first nine months of 2024 (including the sale of South Carolina and Alabama hospitals), which did not recur in 2025.
- Volume Trends: Hospital Operations saw a 6.3% decrease in total admissions and a 10.9% decrease in total surgeries in Q3 2025, largely due to the divestiture of Alabama hospitals in late 2024. Conversely, Ambulatory Care consolidated cases increased 6.2%.
- Cost Management: Salaries, wages, and benefits decreased 0.6% in Q3 2025. However, supplies expense increased 5.7% due to higher patient acuity and volume in the Ambulatory segment.
Guidance, Outlook, and Risks
- Capital Allocation: The company repurchased $1.188 billion of common stock YTD 2025. As of September 30, 2025, $1.688 billion remained available under the share repurchase program.
- Capital Expenditures: Management anticipates full-year 2025 capital expenditures to range between $875 million and $975 million.
- Legislative Impact: The "One Big Beautiful Bill Act" (OBBBA) was enacted in July 2025. While the company does not expect a material impact on current-year tax expense, future provisions (effective 2027) regarding Medicaid work requirements and eligibility could materially impact funding and enrollment.
- Key Risks: Significant risks include potential reductions in government healthcare funding (Medicare/Medicaid), changes in reimbursement rates, cybersecurity incidents, and the impact of the OBBBA on Medicaid eligibility and state budgets.
Investor Verification Checklist
- Non-Recurring Gains: Verify the impact of the $2.9 billion gain on facility sales in 2024 on year-over-year profitability comparisons; 2025 results reflect organic operations without these one-time gains.
- Divestiture Impact: Confirm the extent to which the 2024 sale of Alabama hospitals affects current volume and revenue comparisons in the Hospital Operations segment.
- Debt Structure: Review the maturity schedule of the $12.66 billion in senior notes, with maturities staggered from 2027 to 2031, and the $1.5 billion available credit facility.
- Legislative Exposure: Assess the potential long-term financial impact of the OBBBA on Medicaid reimbursement and patient enrollment, particularly in states that have expanded Medicaid.
- Share Repurchases: Monitor the remaining $1.688 billion authorization and the company's commitment to returning capital to shareholders amidst operational headwinds.